Cordero-Coma Miguel, Salazar-Méndez Raquel, Garzo-García Irene, Yilmaz Taygan
Department of Ophthalmology, University Hospital of León , León , Spain +34 987237400 ; +34 987233322 ;
Expert Opin Drug Saf. 2015 Jan;14(1):111-26. doi: 10.1517/14740338.2015.972363. Epub 2014 Oct 17.
Drug-induced uveitis is a well described but often overlooked and/or misdiagnosed adverse reaction to medication. There are an increasing number of medications that have been related to the onset of intraocular inflammation. Identification of these inciting agents may decisively help the diagnostic algorithm involving new cases of uveitis.
This review intends to be an updated comprehensive, practical guide for practitioners regarding the main drugs that have been associated with uveitis. A classification proposed by Naranjo et al. in 1981 for establishing potential causality is applied examining possible mechanisms of action. A guide for clinicians about the rationale of these observations when dealing with patients with uveitis is provided.
Several agents with different routes of administration (systemic, topical and/or intraocular) may cause intraocular inflammation. The mechanism behind ocular inflammation is frequently unknown. Clinicians should be aware of the potential drug effect to optimize diagnosis and management of such patients.
药物性葡萄膜炎是一种已被充分描述但常被忽视和/或误诊的药物不良反应。越来越多的药物与眼内炎症的发生有关。识别这些诱发因素可能对涉及葡萄膜炎新病例的诊断算法有决定性帮助。
本综述旨在为从业者提供一份关于与葡萄膜炎相关主要药物的最新、全面且实用的指南。应用了1981年纳兰霍等人提出的用于确定潜在因果关系的分类方法来研究可能的作用机制。为临床医生提供了在处理葡萄膜炎患者时对这些观察结果的理论依据的指导。
几种具有不同给药途径(全身、局部和/或眼内)的药物可能会引起眼内炎症。眼内炎症背后的机制通常尚不清楚。临床医生应意识到潜在的药物作用,以优化对此类患者的诊断和管理。